fluocinolone acetonide has been researched along with Cushing Syndrome in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nguyen, DP; Phengrasamy, T; Saberi, P | 1 |
Deleuran, M; Lings, K | 1 |
Borzyskowski, M; Grant, DB; Wells, RS | 1 |
Haynes, RC | 1 |
1 review(s) available for fluocinolone acetonide and Cushing Syndrome
Article | Year |
---|---|
Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management.
Topics: Administration, Inhalation; Administration, Intranasal; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents; Beclomethasone; Child; Child, Preschool; Cushing Syndrome; Drug Interactions; Female; Fluocinolone Acetonide; HIV Protease Inhibitors; HIV Seropositivity; Humans; Infant; Male; Middle Aged; Ritonavir; Young Adult | 2013 |
3 other study(ies) available for fluocinolone acetonide and Cushing Syndrome
Article | Year |
---|---|
[Clinical signs of Cushing's syndrome after long-term local application of steroid in the oral cavity].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Topical; Adult; Anti-Inflammatory Agents; Anti-Ulcer Agents; Cushing Syndrome; Female; Fluocinolone Acetonide; Gastritis; Humans; Lichen Planus, Oral; Mouth Mucosa; Pantoprazole | 2012 |
Cushing's syndrome induced by topical steroids used for the treatment of non-bullous ichthyosiform erythroderma.
Topics: Betamethasone; Betamethasone Valerate; Child; Cushing Syndrome; Emollients; Female; Fluocinolone Acetonide; Humans; Ichthyosis; Infant; Male; Skin Diseases, Vesiculobullous | 1976 |
Hormonal drugs.
Topics: Anti-Inflammatory Agents; Atrophy; Chromatin; Cushing Syndrome; Fibroblasts; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydrocortisone; Lysosomes; Protein Binding; Skin Absorption; Skin Diseases; Structure-Activity Relationship; Vasoconstrictor Agents | 1974 |